About
Technology
Issues
FAQ
Links
Official Page
Efficacy and safety of erlotinib HCl, an epidermal growth factor receptor (HER1/EGFR) tyrosine kinase inhibitor, in patients with advanced ovarian carcinoma: results from a phase II multicenter study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.